The Treatment of Metastatic, Hormone-Sensitive Prostatic Carcinoma.

Axel S Merseburger,Laura-Maria Krabbe, Bernd Joachim Krause,Dirk Böhmer,Sven Perner,Gunhild von Amsberg

Deutsches Arzteblatt international（2022）

引用 3|浏览0

暂无评分

摘要

The treatment of mHSPC is constantly changing. Phase III trials that are now in the recruitment stage, as well as our continually improving understanding of the underlying molecular-pathological mechanisms, will be altering the treatment landscape still further in the years to come.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要